Specialized Treatment Early in Psychosis (STEP)

Completed · Not applicable

Conditions studied: Schizophrenia and Disorders With Psychotic Features

In brief

The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic and psychosocial treatments will be delivered within a state public mental health center.

Key facts

Study ID

NCT00309452

Run by

Yale University

People needed

120

Starts

2006-03-01

Expected to finish

2013-08-01

Last updated by the study team

2017-02-08

Who can join

Age: 16 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 16-45
• Meets DSM-IV schizophrenia spectrum psychosis or affective psychosis according to the SCID
• ≤8 weeks of received antipsychotic treatment lifetime at time of referral
• Willing to be treated in New Haven

You may not qualify if…

• Psychosis believed due to substance use (based on the SCID)
• Unable or unwilling to give informed consent
• MR as indicated by receipt of services from Dept of Mental Retardation

Where it is running

• Connecticut Mental Health Center — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.